URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Ghinwa Dumyati

Concepts (136)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Cross Infection
8
2006
85
1.630
Why?
Community-Acquired Infections
7
2006
27
1.260
Why?
Clostridium difficile
4
2009
13
1.200
Why?
Enterocolitis, Pseudomembranous
3
2009
18
1.150
Why?
Population Surveillance
4
2007
120
1.090
Why?
Staphylococcal Infections
7
2006
103
1.070
Why?
Methicillin-Resistant Staphylococcus aureus
6
2009
17
1.030
Why?
Bacteremia
2
2010
34
0.920
Why?
Catheter-Related Infections
1
2011
11
0.760
Why?
Catheterization, Central Venous
1
2011
59
0.720
Why?
Levamisole
1
2010
4
0.720
Why?
Drug Contamination
1
2010
11
0.710
Why?
Vasculitis, Leukocytoclastic, Cutaneous
1
2010
4
0.710
Why?
Cheek
1
2010
26
0.710
Why?
Ear, External
1
2010
22
0.710
Why?
Cocaine-Related Disorders
1
2010
19
0.700
Why?
Adjuvants, Immunologic
1
2010
118
0.660
Why?
Anti-Bacterial Agents
4
2009
432
0.450
Why?
Cervical Intraepithelial Neoplasia
1
2011
26
0.390
Why?
Papillomavirus Vaccines
1
2011
18
0.390
Why?
Precancerous Conditions
1
2011
36
0.390
Why?
Uterine Cervical Neoplasms
1
2011
125
0.370
Why?
Influenza, Human
2
1992
329
0.350
Why?
Antiviral Agents
1
2002
181
0.340
Why?
Young Adult
6
2009
1013
0.330
Why?
Antibiotic Prophylaxis
2
2008
34
0.310
Why?
Surgical Wound Infection
2
2008
57
0.310
Why?
Methicillin Resistance
2
2006
19
0.290
Why?
Adult
9
2009
10906
0.280
Why?
Humans
20
1992
35000
0.270
Why?
Microbial Sensitivity Tests
3
2009
164
0.270
Why?
Staphylococcus aureus
2
2006
108
0.260
Why?
Middle Aged
9
1992
9461
0.250
Why?
Incidence
3
2010
644
0.240
Why?
Aged
9
1992
6986
0.240
Why?
Prospective Studies
2
2011
1606
0.210
Why?
Sentinel Surveillance
1
2012
2
0.200
Why?
Proton Pump Inhibitors
1
2011
2
0.200
Why?
Virulence Factors
2
2009
75
0.200
Why?
Clostridium Infections
1
2011
6
0.190
Why?
Histamine H2 Antagonists
1
2011
11
0.190
Why?
Catheters
1
2011
5
0.190
Why?
Vancomycin Resistance
1
2011
11
0.190
Why?
New York
2
2009
1191
0.180
Why?
Necrosis
1
2010
99
0.170
Why?
Neutropenia
1
2010
61
0.170
Why?
Staphylococcal Vaccines
1
2009
6
0.170
Why?
Adolescent
6
2009
4513
0.170
Why?
United States
7
2006
2511
0.170
Why?
Staphylococcal Skin Infections
1
2009
4
0.160
Why?
Feces
1
2009
78
0.160
Why?
Genotype
3
2009
455
0.160
Why?
Electrophoresis, Gel, Pulsed-Field
4
2006
24
0.160
Why?
Sequence Analysis, DNA
1
2009
161
0.150
Why?
Quality Indicators, Health Care
1
2008
54
0.150
Why?
Hospitals
1
2008
60
0.150
Why?
Reproducibility of Results
1
2011
859
0.150
Why?
Polymerase Chain Reaction
1
2009
586
0.140
Why?
Female
7
1992
19061
0.130
Why?
Attitude of Health Personnel
1
2009
267
0.130
Why?
Health Knowledge, Attitudes, Practice
1
2009
247
0.130
Why?
Bacterial Proteins
1
2009
373
0.130
Why?
Child, Preschool
4
2009
2452
0.120
Why?
Rimantadine
1
2002
10
0.100
Why?
Zanamivir
1
2002
13
0.100
Why?
Oseltamivir
1
2002
10
0.100
Why?
Pyrans
1
2002
14
0.100
Why?
Amantadine
1
2002
22
0.100
Why?
Guanidines
1
2002
32
0.100
Why?
Child
4
2009
3897
0.100
Why?
Acetamides
1
2002
30
0.100
Why?
Sialic Acids
1
2002
33
0.100
Why?
Drug Resistance, Viral
1
2002
67
0.090
Why?
Aged, 80 and over
4
1992
2423
0.090
Why?
Infant
3
2010
2102
0.090
Why?
Papillomaviridae
1
2011
136
0.090
Why?
Influenza Vaccines
2
1992
239
0.090
Why?
Pilot Projects
1
2011
426
0.090
Why?
Infection Control
2
2009
27
0.090
Why?
DNA Fingerprinting
2
2009
8
0.080
Why?
Practice Guidelines as Topic
1
2002
288
0.080
Why?
Risk Factors
3
2007
2172
0.080
Why?
Hospitalization
2
2011
354
0.080
Why?
Adenocarcinoma
1
2011
431
0.080
Why?
Cohort Studies
2
2009
912
0.070
Why?
Retrospective Studies
2
2011
2167
0.060
Why?
Antibodies, Viral
2
1992
472
0.060
Why?
Male
5
1992
18870
0.060
Why?
Influenza B virus
1
1994
43
0.060
Why?
Treatment Outcome
2
2011
2487
0.060
Why?
Disease Outbreaks
2
1992
109
0.050
Why?
Metronidazole
1
2011
11
0.050
Why?
Fluoroquinolones
1
2011
23
0.050
Why?
Drug Interactions
1
2011
176
0.050
Why?
Health Facilities
1
2010
6
0.050
Why?
England
1
2010
44
0.050
Why?
Risk
1
2011
343
0.040
Why?
Influenza A virus
1
1992
222
0.040
Why?
Proportional Hazards Models
1
2011
398
0.040
Why?
Multivariate Analysis
1
2011
487
0.040
Why?
Bacterial Typing Techniques
1
2009
21
0.040
Why?
Enterotoxins
1
2009
20
0.040
Why?
Cephalexin
1
2009
12
0.040
Why?
Outpatients
1
2009
29
0.040
Why?
Trimethoprim-Sulfamethoxazole Combination
1
2009
13
0.040
Why?
Immunization Programs
1
2009
30
0.040
Why?
ADP Ribose Transferases
1
2009
50
0.040
Why?
Recurrence
1
2011
656
0.040
Why?
Cluster Analysis
1
2009
82
0.040
Why?
Blood
1
2009
92
0.040
Why?
Joints
1
2009
56
0.040
Why?
Bacterial Toxins
1
2009
92
0.040
Why?
Cost of Illness
1
2009
73
0.040
Why?
Feedback
1
2008
71
0.040
Why?
Genetic Variation
1
2009
148
0.040
Why?
DNA, Bacterial
1
2009
167
0.040
Why?
Cooperative Behavior
1
2008
95
0.040
Why?
Aging
1
1994
692
0.040
Why?
Logistic Models
1
2009
581
0.030
Why?
Infant, Newborn
1
2011
1772
0.030
Why?
Sensitivity and Specificity
1
2009
866
0.030
Why?
Bone and Bones
1
2009
330
0.030
Why?
Base Sequence
1
2009
1681
0.030
Why?
Questionnaires
1
2009
942
0.030
Why?
Molecular Sequence Data
1
2009
1993
0.030
Why?
Vaccines, Attenuated
2
1992
82
0.030
Why?
Time Factors
1
2009
3047
0.030
Why?
Double-Blind Method
2
1992
985
0.020
Why?
Cold Temperature
1
1994
97
0.010
Why?
Vaccines, Inactivated
1
1992
38
0.010
Why?
Injections, Intramuscular
1
1992
70
0.010
Why?
Administration, Intranasal
1
1992
62
0.010
Why?
Vaccination
1
1994
197
0.010
Why?
Homes for the Aged
1
1992
60
0.010
Why?
Chronic Disease
1
1994
496
0.010
Why?
Nursing Homes
1
1992
198
0.010
Why?

Visualizations


Dumyati's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department